What is the recommended dose of Macrobid (nitrofurantoin) for treating a urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Macrobid (Nitrofurantoin) for UTI Treatment

The recommended dose of nitrofurantoin (Macrobid) for treating uncomplicated urinary tract infections is 100 mg twice daily for 5-7 days. 1, 2

Dosing Guidelines for Different Patient Populations

Standard Dosing for Uncomplicated UTIs

  • Nitrofurantoin monohydrate/macrocrystals (Macrobid): 100 mg twice daily for 5-7 days 1, 2
  • This dosing regimen is recommended by the Infectious Diseases Society of America (IDSA) and the American College of Physicians as a first-line treatment option 1

Special Populations

  • Breastfeeding women: 100 mg twice daily for 5 days is considered safe and effective 1
  • Pregnant women: Requires urine culture for each symptomatic episode; nitrofurantoin is generally considered safe except during the first trimester 1
  • Patients with diabetes without voiding abnormalities should be treated with the same regimen as patients without diabetes 2

Clinical Efficacy and Treatment Considerations

  • Nitrofurantoin demonstrates excellent efficacy against most uropathogens with bacteriological cure rates of 21/26 (80.8%) after just 3 days of treatment compared to 5/25 (20%) with placebo 3
  • After 7 days of treatment, bacteriological cure rates improve to 17/23 (73.9%) compared to 9/22 (40.9%) with placebo 3
  • The Number Needed to Treat (NNT) for bacteriological cure is approximately 1.6 after 3 days of treatment 3

Monitoring and Follow-up

  • Monitor for clinical response within 48-72 hours of initiating treatment 1
  • If symptoms persist beyond 72 hours, obtain a urine culture with susceptibility testing and adjust therapy accordingly 1
  • No routine post-treatment urinalysis or urine cultures are needed if symptoms resolve 1

Important Considerations and Cautions

  • While some UK guidelines suggest 3-day courses of nitrofurantoin, there is limited direct evidence supporting this shorter duration 4
  • The 5-7 day regimen has more robust evidence for clinical and microbiological efficacy 1, 2, 5
  • Nitrofurantoin has maintained low resistance rates (approximately 2%) compared to other antimicrobials like trimethoprim-sulfamethoxazole (18-22% resistance in some US regions) 1
  • Common side effects include mild headache (reported in about 10.8% of patients) and rash 5

Alternative First-line Options When Nitrofurantoin Cannot Be Used

  • Trimethoprim-sulfamethoxazole: 160/800 mg twice daily for 3 days (if local resistance is <20%) 1, 2
  • Fosfomycin trometamol: 3 g single dose 1, 2

Remember that nitrofurantoin should be taken with food to improve absorption and reduce gastrointestinal side effects, and patients should be advised to complete the full course of treatment even if symptoms improve before completion.

References

Guideline

Urinary Tract Infections in Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women.

The British journal of general practice : the journal of the Royal College of General Practitioners, 2002

Research

Nitrofurantoin: what is the evidence for current UK guidance?

The Journal of antimicrobial chemotherapy, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.